Loading clinical trials...
Loading clinical trials...
A 5-year, Randomized, Double-blind, Placebo-controlled, Multi-center Study Assessing the Efficacy, Safety, and Tolerability of Intra-articular Regimens of LNA043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis
Conditions
Interventions
LNA043 Dosing Regimen A
LNA043 Dosing Regimen B
+3 more
Locations
76
United States
Elite Clinical Studies
Phoenix, Arizona, United States
Tucson Orthopedic Institute PC
Tucson, Arizona, United States
Sharps Hospital Grossmont
La Mesa, California, United States
Clinical Trials Research
Lincoln, California, United States
Long Beach Clinical Trials
Long Beach, California, United States
Artemis Institute Clinical Research
Riverside, California, United States
Start Date
May 31, 2021
Primary Completion Date
September 29, 2024
Completion Date
May 29, 2025
Last Updated
July 24, 2025
NCT07153471
NCT07351968
NCT06747494
NCT06381791
NCT07327931
NCT06906939
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions